By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Department of Defense has awarded Boston University Medical School a $13.6 million grant to lead a multi-site study to discover molecular biomarkers that can be used for the early detection of lung cancer.

The five-year study will seek to identify markers that could help physicians decide which patients require biopsies after having CT scans and could predict which smokers who had no abnormalities in their CT scans will be most likely to get lung cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.